EATG » Comorbidities

Comorbidities

Immunotherapy is safe and feasible in cancer patients treated for HIV, study suggests

Results raise hopes that HIV-positive cancer patients could benefit from innovative treatment option Munich, Germany, 20 October 2018 - Immunotherapy has been a major breakthrough in oncology, with registered drugs…

Young adults’ cancer survival rates jump in surprising new study

USC analysis shows that 15- to 39-year-olds had the best survival of any age group for many years after HIV/AIDS-related cancers are taken into account Young Americans with cancer have…

Study finds no link between neurocognitive impairment, depression in HIV patients

SAN FRANCISCO — Findings from a retrospective study presented at IDWeek showed no association between neurocognitive impairment and depression in patients with HIV. “I was talking to mentor, Zsofi Szep…

Internet-based intervention can reduce depression in people living with HIV

A guided internet-based intervention can effectively reduce depressive symptoms for people living with HIV, according to results published in Lancet HIV. The study included participants from 23 HIV treatment centers in…

Infections common in patients coinfected with HIV/HCV taking direct-acting antivirals

In patients with HIV/hepatitis C virus (HCV)-coinfection who receive oral direct-acting antiviral agents (DAAs) severe infections are relatively common, according to study results published in the Journal of Viral Hepatology. The…

Mental health problems in adolescents with HIV: Overview & expert interview

Substantially less mental health research has been conducted in young adults and adolescents compared with adults, and such evidence is especially sparse in resource-limited settings.1Noting that the burden of illness…

Chronic pain is a huge, underrecognized problem for people with HIV

Living with chronic pain not only drags down quality of life, but it is also linked to poorer HIV-related health outcomes. For the first 15 years of the HIV epidemic,…

HIV impacts neurocognition in resource-limited settings

Despite big advances in the field of HIV treatment, including streamlined drug regimens that help infected individuals achieve normal or near-normal lifespans, living with HIV often means dealing with neurocognitive impairment of…

ART reduces neurocognitive impairment in patients living with HIV

Initiating antiretroviral therapy (ART) may reduce the risk for neurocognitive impairment in patients living with HIV, according to study results published in Clinical Infectious Diseases. The study included participants from the…

Polypharmacy prevalence trends in HIV-positive men in the United States

While polypharmacy is expected to be prevalent in men who are HIV-positive, researchers have found that polypharmacy prevalence of non-HIV medications appears to increase over time in people living with…